Skip to main content
. Author manuscript; available in PMC: 2026 Apr 17.
Published in final edited form as: Clin Microbiol Infect. 2023 May 25;29(12):1474–1479. doi: 10.1016/j.cmi.2023.05.024

Table 2.

Patient enrolment criteria

Inclusion criteria Adult patient (≥18 y)
Underlying diagnosis of haematological malignancy (acute leukaemia, chronic myeloid neoplasm, B, T, and/or NK cell lymphoma, histiocytic neoplasm, and multiple myeloma)
Neutropenia (absolute neutrophil count <500 cells/μL)
Fever documented single oral temperature ≥101 °F (38.3 °C), or a temperature of ≥100.4 °F (38 °C) for at least an hour
Exclusion criteria Prior targeted antibiotic therapy for >24 h (excluding prophylactic antibiotics)a
Adequate blood sample not available Failure to obtain informed consent
Patient is not expected to survive >24 h beyond the time of potential study enrolment visit
a

Culture recovery can be compromised as the length of antibiotic treatment increases.